Safety study of cariprazine in manic episodes in bipolarity type I
This study is completed in the United States and in India. It is testing cariprazine for manic episodes in bipolarity type I.
Bipolarity, ManiaDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether the Safety and Efficacy of Cariprazine may be useful for adults experiencing bipolarity.
What would participation involve?
Participants may receive the Safety and Efficacy of Cariprazine, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in India and in the United States.
Who is it mainly for?
This study appears to be mainly for adults with bipolarity.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateFebruary 2010
Recruitment status
Completed
Enrollment listed in the registry
323
Sponsor
Forest Laboratories
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, India
Age range
From 18 Years to 65 Years
Official registry ID
NCT01058096
Official title
A Double-Blind, Placebo-Controlled, Evaluation of the Safety and Efficacy of Cariprazine in Patients With Acute Mania Associated With Bipolar I Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01058096. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
India · 18 sites
Forest Investigative Site 106
Vijayawada, Andhra Pradesh
Site status: Not listed — confirm with the team
Forest Investigative Site 112
Vizag, Andhra Pradesh
Site status: Not listed — confirm with the team
Forest Investigator Site 108
Varanasi, Durgakund
Site status: Not listed — confirm with the team
Forest Investigative Site 103
Ahmedabad, Gujarat
Site status: Not listed — confirm with the team
Forest Investigative Site 120
Ahmedabad, Gujarat
Site status: Not listed — confirm with the team
Forest Investigative Site 105
Bangalore, Karnataka
Site status: Not listed — confirm with the team
Forest Investigative Site 107
Bangalore, Karnataka
Site status: Not listed — confirm with the team
Forest Investigative Site 118
Mangalore, Karnataka
Site status: Not listed — confirm with the team
Forest Investigative Site 113
Mangalore, Karnataka
Site status: Not listed — confirm with the team
Forest Investigative Site 115
Manipal, Karnataka
Site status: Not listed — confirm with the team
Forest Investigative Site 114
Mysore, Karnataka
Site status: Not listed — confirm with the team
Forest Investigative Site 101
Aurangabad, Maharashtra
Site status: Not listed — confirm with the team
Forest Investigative Site 110
Nashik, Maharashtra
Site status: Not listed — confirm with the team
Forest Investigative Site 111
Pune, Maharashtra
Site status: Not listed — confirm with the team
Forest Investigative Site 104
Pune, Maharashtra
Site status: Not listed — confirm with the team
Forest Investigative Site 121
Chennai, Tamil Nadu
Site status: Not listed — confirm with the team
Forest Investigative Site 109
Kanpur, Uttar Pradesh
Site status: Not listed — confirm with the team
Forest Investigative Site 119
Lucknow, Uttar Pradesh
Site status: Not listed — confirm with the team
United States · 10 sites
Forest Investigative Site 004
Long Beach, California
Site status: Not listed — confirm with the team
Forest Investigative Site 005
Riverside, California
Site status: Not listed — confirm with the team
Forest Investigative Site 007
San Diego, California
Site status: Not listed — confirm with the team
Forest Investigative Site 009
Chicago, Illinois
Site status: Not listed — confirm with the team
Forest Investigative Site 006
Lake Charles, Louisiana
Site status: Not listed — confirm with the team
Forest Investigative Site 001
Flowood, Mississippi
Site status: Not listed — confirm with the team
Forest Investigative Site 003
Creve Couer, Missouri
Site status: Not listed — confirm with the team
Forest Investigative Site 008
Cleveland, Ohio
Site status: Not listed — confirm with the team
Forest Investigative Site 010
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
Forest Investigative Site 002
Houston, Texas
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Cariprazine, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: From 18 Years to 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Forest Laboratories, which appears to be a pharmaceutical company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
